Canadian business executive, Tom Gaglardi, President of Northland Properties Corporation and owner of the Dallas Stars ice hockey team, presented a generous gift of CAD 3 million to JDRF Canada to support cure-related research activities in the areas of encapsulation, and beta cell replacement and regeneration.
Gaglardi’s gift will support JDRF’s global efforts to advance international type 1 diabetes research projects and foster collaboration of the best and brightest scientific minds working on encapsulation therapies to develop a cure for the disease. Gaglardi gave the gift at April’s 2017 JDRF Greater Dallas Dream Gala.
“As the parent of a child with type 1 diabetes, I am incredibly proud to support JDRF in funding the kind of critical research that will improve the lives of people living with this disease,” says Gaglardi.
Through the JDRF Encapsulation Research Program, more than 50 scientists around the world are developing ways to generate or produce an unlimited supply of beta cells, as well as revolutionary biotechnologies consisting of protective barriers and devices that can be implanted in people with type 1 diabetes, and shield beta cells from immune system attack.
“We are on the verge of defeating a disease that affects so many people in Canada – and around the world,” says Dave Prowten, President and CEO at JDRF Canada. “Each day we are getting closer to finding a cure, and we are very grateful to Tom and his family for their generous contribution.”
“Tom Gaglardi’s extraordinary gift will move us meaningfully closer to our goal of turning type 1 diabetes into type none,” says Derek Rapp, President and Chief Executive Officer, JDRF International. “On behalf of everyone whose life is touched by type 1 diabetes, I thank Tom and his family.”